A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Public ClinicalTrials.gov record NCT06968845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Efficacy of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Patients With Idiopathic Pulmonary Fibrosis
Study identification
- NCT ID
- NCT06968845
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Rein Therapeutics
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Dry Powder Inhaler Device
- LTI-03 Drug
- Placebo Drug
Device · Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 1, 2026
- Primary completion
- Sep 29, 2027
- Completion
- Dec 30, 2027
- Last update posted
- May 6, 2026
2026 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Lung Health Center | Birmingham | Alabama | 35233 | Recruiting |
| Paradigm Clinical Research Centers, LLC | San Diego | California | 92108 | Recruiting |
| Yale University School of Medicine | New Haven | Connecticut | 06511 | Recruiting |
| Henry Ford Health | Detroit | Michigan | 48202 | Recruiting |
| The Lung Research Center, LLC | Chesterfield | Missouri | 63017 | Recruiting |
| University of Kansas Medical Center | Kansas City | Missouri | 66160 | Recruiting |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Recruiting |
| El Paso Pulmonary Association | El Paso | Texas | 79902 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06968845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06968845 live on ClinicalTrials.gov.